{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:02:56Z","timestamp":1759971776423,"version":"build-2065373602"},"reference-count":40,"publisher":"The Endocrine Society","issue":"11","license":[{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Stockholm Regional Council","award":["FOUI-973669"],"award-info":[{"award-number":["FOUI-973669"]}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Primary hyperparathyroidism (PHPT) presents both in sporadic and hereditary forms, with familial clustering observed in certain genetic syndromes. While emerging research suggests an increased malignancy risk in patients, the extent to which this association extends to their first-degree relatives remains unclear. Understanding familial aggregation of PHPT and malignancies could reveal underlying genetic risk factors and guide clinical management.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>This work aimed to assess familial clustering of PHPT and malignancies among first-degree relatives of affected patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A nationwide register-based case-control and cohort study was conducted including all patients with PHPT who underwent parathyroidectomy between 2008 and 2017, with matched controls and their first-degree relatives. This Swedish, nationwide, population-based register study included 6693 patients born in Sweden after 1932 who were matched with 33 393 controls. Main outcome measures included diagnoses of PHPT and malignancies among first-degree relatives.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 218 729 first-degree relatives were identified. Relatives of patients had statistically significantly higher odds of PHPT, particularly if diagnosed at age 45 years or younger (odds ratio [OR] 7.7; 95% CI, 5.23-11.34; P &amp;lt; .001). The risk of malignancy was slightly increased (OR 1.07; 95% CI, 1.01-1.13; P = .017), due to prostate, nonmedullary thyroid, and hematologic malignancies. In prospective analysis, no increased risk of malignancy in relatives was observed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This study highlights a significant familial aggregation of PHPT, particularly in early-onset cases. Although a modest overrepresentation of a family history of malignancy was observed, this may reflect multiple comparisons and surveillance bias rather than a true causal link between PHPT and cancer.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jendso\/bvaf152","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T13:17:20Z","timestamp":1758633440000},"source":"Crossref","is-referenced-by-count":1,"title":["Familial Aggregation of Primary Hyperparathyroidism and Malignancy\u2014Nationwide Case-Control and Cohort Study"],"prefix":"10.1210","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1043-1733","authenticated-orcid":false,"given":"David","family":"Thorsteinsson","sequence":"first","affiliation":[{"name":"Department of Breast, Endocrine Tumors and Sarcoma, Karolinska University Hospital , 171 76 Stockholm ,","place":["Sweden"]},{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet , 171 76 Stockholm ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrik","family":"Granath","sequence":"additional","affiliation":[{"name":"Department of Medicine Solna, Division of Clinical Epidemiology, Karolinska Institutet , 171 76 Stockholm ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6245-7223","authenticated-orcid":false,"given":"Robert","family":"Br\u00e4nstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Breast, Endocrine Tumors and Sarcoma, Karolinska University Hospital , 171 76 Stockholm ,","place":["Sweden"]},{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet , 171 76 Stockholm ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2833-3758","authenticated-orcid":false,"given":"Jan","family":"Zedenius","sequence":"additional","affiliation":[{"name":"Department of Breast, Endocrine Tumors and Sarcoma, Karolinska University Hospital , 171 76 Stockholm ,","place":["Sweden"]},{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet , 171 76 Stockholm ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8966-3729","authenticated-orcid":false,"given":"Inga-Lena","family":"Nilsson","sequence":"additional","affiliation":[{"name":"Department of Breast, Endocrine Tumors and Sarcoma, Karolinska University Hospital , 171 76 Stockholm ,","place":["Sweden"]},{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet , 171 76 Stockholm ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"issue":"10","key":"2025100812265450500_bvaf152-B1","doi-asserted-by":"crossref","first-page":"e1117","DOI":"10.1210\/clinem\/dgad201","article-title":"Stable incidence and increasing prevalence of primary hyperparathyroidism in a population-based study in Scotland","volume":"108","author":"Soto-Pedre","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2025100812265450500_bvaf152-B2","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00423-015-1342-7","article-title":"Hereditary hyperparathyroidism\u2014a consensus report of the European society of endocrine surgeons (ESES)","volume":"400","author":"Iacobone","year":"2015","journal-title":"Langenbecks Arch Surg"},{"issue":"9","key":"2025100812265450500_bvaf152-B3","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1007\/s40618-024-02366-7","article-title":"Familial states of primary hyperparathyroidism: an update","volume":"47","author":"Cetani","year":"2024","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2025100812265450500_bvaf152-B4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/his.13306","article-title":"Heritable forms of primary hyperparathyroidism: a current perspective","volume":"72","author":"DeLellis","year":"2018","journal-title":"Histopathology"},{"issue":"6","key":"2025100812265450500_bvaf152-B5","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/joim.12523","article-title":"Genetics of parathyroid tumours","volume":"280","author":"Thakker","year":"2016","journal-title":"J Intern Med"},{"issue":"1","key":"2025100812265450500_bvaf152-B6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s42000-023-00508-9","article-title":"Genetics of hereditary forms of primary hyperparathyroidism","volume":"23","author":"English","year":"2024","journal-title":"Hormones (Athens)"},{"key":"2025100812265450500_bvaf152-B7","doi-asserted-by":"crossref","first-page":"623667","DOI":"10.3389\/fendo.2021.623667","article-title":"Familial hyperparathyroidism","volume":"12","author":"Blau","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2025100812265450500_bvaf152-B8","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ajhg.2016.08.018","article-title":"GCM2-Activating mutations in familial isolated hyperparathyroidism","volume":"99","author":"Guan","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"2","key":"2025100812265450500_bvaf152-B9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/joim.12840","article-title":"Primary hyperparathyroidism: should surgery be performed on all patients? Current evidence and residual uncertainties","volume":"285","author":"Nilsson","year":"2019","journal-title":"J Intern Med"},{"issue":"1","key":"2025100812265450500_bvaf152-B10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1677\/erc.1.01261","article-title":"The association between primary hyperparathyroidism and malignancy: nationwide cohort analysis on cancer incidence after parathyroidectomy","volume":"14","author":"Nilsson","year":"2007","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"2025100812265450500_bvaf152-B11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/1097-0142(19870801)60:3<429::AID-CNCR2820600325>3.0.CO;2-3","article-title":"Familial hyperparathyroidism in association with colonic carcinoma","volume":"60","author":"Feig","year":"1987","journal-title":"Cancer"},{"issue":"3","key":"2025100812265450500_bvaf152-B12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/ijc.20155","article-title":"Hyperparathyroidism and subsequent incidence of breast cancer","volume":"110","author":"Michels","year":"2004","journal-title":"Int J Cancer"},{"issue":"8","key":"2025100812265450500_bvaf152-B13","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/cncr.10846","article-title":"Hyperparathyroidism and subsequent cancer risk in Denmark","volume":"95","author":"Pickard","year":"2002","journal-title":"Cancer"},{"issue":"2","key":"2025100812265450500_bvaf152-B14","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s12020-017-1351-0","article-title":"Mineral metabolism abnormalities in patients with prostate cancer: a systematic case controlled study","volume":"59","author":"Minisola","year":"2018","journal-title":"Endocrine"},{"issue":"5","key":"2025100812265450500_bvaf152-B15","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/oxfordjournals.aje.a114879","article-title":"Increased risk of malignant diseases after surgery for primary hyperparathyroidism. A nationwide cohort study","volume":"127","author":"Palmer","year":"1988","journal-title":"Am J Epidemiol"},{"key":"2025100812265450500_bvaf152-B16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejim.2017.06.001","article-title":"Occurrence of malignant neoplasia in patients with primary hyperparathyroidism","volume":"43","author":"Palmieri","year":"2017","journal-title":"Eur J Intern Med"},{"issue":"4","key":"2025100812265450500_bvaf152-B17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1365-2362.1998.00289.x","article-title":"Increased risk of death from primary hyperparathyroidism--an update","volume":"28","author":"Hedb\u00e4ck","year":"1998","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"2025100812265450500_bvaf152-B18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2265.2009.03766.x","article-title":"Increased mortality and morbidity in mild primary hyperparathyroid patients. The parathyroid epidemiology and audit research study (PEARS)","volume":"73","author":"Yu","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2025100812265450500_bvaf152-B19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00223-024-01219-y","article-title":"Risk of malignant neoplasm in patients with primary hyperparathyroidism: a systematic review and meta-analysis","volume":"115","author":"Charoenngam","year":"2024","journal-title":"Calcif Tissue Int"},{"issue":"9596","key":"2025100812265450500_bvaf152-B20","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"2025100812265450500_bvaf152-B21","doi-asserted-by":"crossref","first-page":"zrad154","DOI":"10.1093\/bjsopen\/zrad154","article-title":"Regional variations in the management of primary hyperparathyroidism in Sweden: population-based case-control study","volume":"8","author":"Thorsteinsson","year":"2024","journal-title":"BJS Open"},{"year":"2017","author":"Statistics-Sweden","key":"2025100812265450500_bvaf152-B22"},{"key":"2025100812265450500_bvaf152-B23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/978-1-59745-423-0_10","article-title":"The Swedish multi-generation register","volume":"675","author":"Ekbom","year":"2011","journal-title":"Methods Mol Biol"},{"key":"2025100812265450500_bvaf152-B24","doi-asserted-by":"crossref","unstructured":"Thorsteinsson D, Granath F, Branstrom R, Koman A, Zedenius J, Nilsson IL. 2025. Supplementary materials for: Familial aggregation of primary hyperparathyroidism and malignancy\u2014nationwide case-control and cohort study. Zenodo. doi:10.5281\/zenodo.15207336","DOI":"10.1210\/jendso\/bvaf152"},{"issue":"1","key":"2025100812265450500_bvaf152-B25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/02841860802247664","article-title":"The completeness of the Swedish cancer register: a sample survey for year 1998","volume":"48","author":"Barlow","year":"2009","journal-title":"Acta Oncol"},{"issue":"43","key":"2025100812265450500_bvaf152-B26","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J Open Source Softw"},{"journal-title":"Version 3.8-3","year":"2024","author":"Therneau","key":"2025100812265450500_bvaf152-B27"},{"issue":"3","key":"2025100812265450500_bvaf152-B28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"issue":"2","key":"2025100812265450500_bvaf152-B29","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1530\/EJE-21-1044","article-title":"European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE educational program of parathyroid disorders","volume":"186","author":"Bollerslev","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2025100812265450500_bvaf152-B30","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surg"},{"issue":"1","key":"2025100812265450500_bvaf152-B31","first-page":"10","article-title":"Nationellt v\u00e5rdprogram f\u00f6r prim\u00e4r hyperparatyreoidism","author":"Nilsson","year":"2023","journal-title":"Swedish national guidelines"},{"issue":"5","key":"2025100812265450500_bvaf152-B32","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1210\/endrev\/bnad009","article-title":"Molecular and clinical Spectrum of primary hyperparathyroidism","volume":"44","author":"Jha","year":"2023","journal-title":"Endocr Rev"},{"issue":"6","key":"2025100812265450500_bvaf152-B33","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1053\/j.ajkd.2007.07.031","article-title":"Elevated fibroblast growth factor 23 in a patient with metastatic prostate cancer and hypophosphatemia","volume":"50","author":"Cotant","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"2025100812265450500_bvaf152-B34","doi-asserted-by":"crossref","first-page":"9461079","DOI":"10.1155\/2018\/9461079","article-title":"Symptomatic primary hyperparathyroidism as a risk factor for differentiated thyroid cancer","volume":"2018","author":"Vargas-Ortega","year":"2018","journal-title":"J Thyroid Res"},{"issue":"8","key":"2025100812265450500_bvaf152-B35","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1530\/EC-21-0217","article-title":"Increased thyroid malignancy in patients with primary hyperparathyroidism","volume":"10","author":"Li","year":"2021","journal-title":"Endocr Connect"},{"issue":"1","key":"2025100812265450500_bvaf152-B36","first-page":"42","article-title":"Is primary hyperparathyroidism a risk factor for papillary thyroid cancer? An exemplar study and literature review","volume":"19","author":"Cinamon","year":"2015","journal-title":"Int Arch Otorhinolaryngol"},{"key":"2025100812265450500_bvaf152-B37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2147\/CLEP.S17298","article-title":"Breast cancer associated with primary hyperparathyroidism: a nested case control study","volume":"3","author":"Norenstedt","year":"2011","journal-title":"Clin Epidemiol"},{"issue":"6","key":"2025100812265450500_bvaf152-B38","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/jmedgenet-2017-104882","article-title":"Evidence for genetic anticipation in vonHippel-Lindau syndrome","volume":"55","author":"Aronoff","year":"2018","journal-title":"J Med Genet"},{"issue":"10","key":"2025100812265450500_bvaf152-B39","doi-asserted-by":"crossref","first-page":"e1007012","DOI":"10.1371\/journal.pgen.1007012","article-title":"Genetic anticipation in Swedish Lynch syndrome families","volume":"13","author":"von Salom\u00e9","year":"2017","journal-title":"PLoS Genet"},{"issue":"7","key":"2025100812265450500_bvaf152-B40","doi-asserted-by":"crossref","first-page":"dgaa257","DOI":"10.1210\/clinem\/dgaa257","article-title":"Clues for genetic anticipation in multiple endocrine neoplasia type 1","volume":"105","author":"van den Broek","year":"2020","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvaf152\/64354047\/bvaf152.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/9\/11\/bvaf152\/64354047\/bvaf152.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/9\/11\/bvaf152\/64354047\/bvaf152.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:27:04Z","timestamp":1759940824000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvaf152\/8262322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,10,8]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvaf152","relation":{},"ISSN":["2472-1972"],"issn-type":[{"type":"electronic","value":"2472-1972"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,9,23]]},"article-number":"bvaf152"}}